Evolutionary optimization, backpropagation, and data preparation issues in QSAR modeling of HIV inhibition by HEPT derivatives

Baba, 1989, Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative, Biochem. Biophys. Res. Commun., 165, 1375, 10.1016/0006-291X(89)92756-3

Efron, B., Tibshirani, R.J., 1993. An Introduction to the Bootstrap. Chapman and Hall, London.

Fogel, 1991, An information criterion for optimal neural network selection, IEEE Trans. Neural Networks, 2, 490, 10.1109/72.134286

Fogel, D.B., 2000. Evolutionary Computation: Toward a New Philosophy of Machine Intelligence, 2nd ed. IEEE Press, Piscataway, NJ.

Fogel, 1998, Evolving neural networks for screening features from mammograms, Artif. Int. Med., 14, 317, 10.1016/S0933-3657(98)00040-2

Gussio, 1996, All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: a 3D QSAR approach, J. Med. Chem., 39, 1645, 10.1021/jm9508088

Gussio, R., Pattabriaman, N., Kellogg, G.E., Zaharevitz, D.W., 1998. Use of 3D QSAR methodology for data mining the National Cancer Institute repository of small molecules: applications to HIV-1 reverse transcriptase inhibition. In: METHODS: A Companion to Methods in Enzymology, vol. 14, pp. 255–263.

Hannongbua, 1996, Structure–activity correlation study of HIV-1 inhibitors: electron and molecular parameters, J. Comput.-Aided Mol. Design, 10, 145, 10.1007/BF00402822

Hannongbua, 1996, Comparative molecular field analysis of HIV-1 reverse transcriptase inhibitors in the class of 1-[(2-hydroxyehtoxy)methyl-6-(phenylthio)-thymine], Quant. Struct.-Act. Relat., 15, 389, 10.1002/qsar.19960150504

Jalali-Heravi, 2000, Use of artificial neural networks in a QSAR study of anti-HIV activity for a large group of HEPT derivatives, J. Chem. Inf. Comput. Sci., 40, 147, 10.1021/ci990314+

Kireev, 1997, A 3D QSAR study of a series of HEPT analogous: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition, J. Med. Chem., 40, 4257, 10.1021/jm970110p

Landavazo, D., Fogel, G.B., 2002. Evolved neural networks for quantitative structure–activity relationships of anti-HIV compounds. In: Proceedings of the 2002 Congress on Evolutionary Computation, Honolulu, HI. IEEE Press, Piscataway, NJ.

Landavazo, 2002, Quantitative structure–activity relationships by evolved neural networks for the inhibition of dihydrofolate reductase by pyrimidines, BioSystems, 65, 37, 10.1016/S0303-2647(01)00192-7

Luco, 1997, QSAR based on multiple linear regression and PLS methods for the anti-HIV activity of a large group of HEPT derivatives, J. Chem. Inf. Comput. Sci., 37, 392, 10.1021/ci960487o

Luke, 1994, Evolutionary programming applied to the development of quantitative structure–activity relationships and quantitative structure–property relationships, J. Chem. Inf. Comput. Sci., 34, 1279, 10.1021/ci00022a009

Porto, W.V., Fogel, D.B., Fogel, L.J., 1995. Alternative neural network training methods. IEEE Expert, June, pp. 16–22.

Selassie, 2002, QSAR: then and now, Curr. Top. Med. Chem., 2, 1357, 10.2174/1568026023392823

Sokal, R.R., Rohlf, J., 1987. Introduction to Biostatistics, 2nd ed. W.H. Freeman and Company, New York.

Tanaka, 1992, Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents, J. Med. Chem., 35, 4713, 10.1021/jm00103a009

Werbos, P., 1974. Beyond regression: new tools for prediction and analysis in the behavioral sciences. Doctoral dissertation, Harvard, Cambridge, MA.

Yao, 1999, Evolving artificial neural networks, Proc. IEEE, 87, 1423, 10.1109/5.784219